TEVIMBRA 10 mg/mL
tislelizumab-jsgr · INJECTION, SOLUTION, CONCENTRATE · BeOne Medicines USA, Inc.
TEVIMBRA is a injection, solution, concentrate containing tislelizumab-jsgr at 10 mg/mL, taken intravenous. Manufactured by BeOne Medicines USA, Inc..
Key Facts
- Brand Name
- TEVIMBRA
- Generic Name
- tislelizumab-jsgr
- NDC Code (Product)
72579-121- Manufacturer
- BeOne Medicines USA, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761232
- Marketing Start
- 03/14/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is TEVIMBRA used for?
TEVIMBRA contains tislelizumab-jsgr. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is TEVIMBRA a controlled substance?
TEVIMBRA is not classified as a controlled substance by the DEA.
What is the generic name for TEVIMBRA?
The generic name for TEVIMBRA is tislelizumab-jsgr. There are no other listed brand versions of tislelizumab-jsgr.
What is the NDC code for TEVIMBRA 10 mg/mL?
The NDC (National Drug Code) for TEVIMBRA 10 mg/mL is 72579-121, listed by BeOne Medicines USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)